Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
نویسندگان
چکیده
منابع مشابه
ACUTE EXTRAPYRAMIDAL SYMPTOMS FOLLOWING ABRUPT DISCONTINUATION OF PROPRANOLOL
A case of acute extrapyramidal manifestations consisting of dystonia and akathisia following abrupt discontinuation of propranolol is reported. She responded well to oral propranolol and intramuscular diazepam. Extrapyramidal symptoms have commonly been associated with acute or chronic administration of neuroleptic drugs. There have been reports of a substantial number of cases with simila...
متن کاملWhy does milnacipran produce so few discontinuation syndromes following abrupt withdrawal?
Several selective serotonin reuptake inhibitors (SSRI), especially paroxetine, have been reported to produce a number of post-treatment emergent adverse events following abrupt withdrawal (Coupland et al 1996; Haddad 1997). More recently a SSRI-induced neonatal withdrawal syndrome has been described (Sanz et al 2005) in infants born of mothers treated with SSRI during pregnancy. In both of thes...
متن کاملUtilisation of psychotropic medications
The timely article by Verdoux & Begaud ́ hopefully begins to redress the imbalance between randomised controlled trials and other ways of evaluating drug treatments. I would like to present further evidence for the ‘gap between guidelines and utilisation . . . for psychotropic medications’ (Verdoux & Begaud, 2004). ́ Using the Drug Report of the German Public Health Insurance (Schwabe & Pfaffrath...
متن کاملUtilisation of psychotropic medications
The timely article by Verdoux & Begaud ́ hopefully begins to redress the imbalance between randomised controlled trials and other ways of evaluating drug treatments. I would like to present further evidence for the ‘gap between guidelines and utilisation . . . for psychotropic medications’ (Verdoux & Begaud, 2004). ́ Using the Drug Report of the German Public Health Insurance (Schwabe & Pfaffrath...
متن کاملUtilisation of psychotropic medications.
The timely article by Verdoux & Begaud ́ hopefully begins to redress the imbalance between randomised controlled trials and other ways of evaluating drug treatments. I would like to present further evidence for the ‘gap between guidelines and utilisation . . . for psychotropic medications’ (Verdoux & Begaud, 2004). ́ Using the Drug Report of the German Public Health Insurance (Schwabe & Pfaffrath...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Psychotherapy and Psychosomatics
سال: 2020
ISSN: 0033-3190,1423-0348
DOI: 10.1159/000506868